Mueller Water Products, Inc. (MWA) /
The cash flow of Mueller Water Products, Inc. over the past 10 years
Chart Mueller Water Products, Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Mueller Water Products, Inc.'s operating cash flow was $219.3M and its capital expenditures $47.3M, leaving free cash flow of $172M. Free cash flow was above zero in 9 of the 10 years shown. It ranged from -$2.4M in fiscal 2022 to $191.4M in fiscal 2024. Capital expenditures were highest in fiscal 2019, at $86.6M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Sep 30, 2025 | $219.3M | $47.3M | $172M |
| 2024ended Sep 30, 2024 | $238.8M | $47.4M | $191.4M |
| 2023ended Sep 30, 2023 | $109M | $47.6M | $61.4M |
| 2022ended Sep 30, 2022 | $52.3M | $54.7M | -$2.4M |
| 2021ended Sep 30, 2021 | $156.7M | $62.7M | $94M |
| 2020ended Sep 30, 2020 | $140.3M | $67.7M | $72.6M |
| 2019ended Sep 30, 2019 | $92.5M | $86.6M | $5.9M |
| 2018ended Sep 30, 2018 | $133.1M | $55.7M | $77.4M |
| 2017ended Sep 30, 2017 | $59.4M | $40.6M | $18.8M |
| 2016ended Sep 30, 2016 | $114.5M | $31.5M | $83M |
Fiscal years as Mueller Water Products, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Mueller Water Products, Inc.
- The revenue of Mueller Water Products, Inc.
- The profitability of Mueller Water Products, Inc.
- The debt of Mueller Water Products, Inc.
- The dividends of Mueller Water Products, Inc.
- All of Mueller Water Products, Inc.'s financials, charted
Companies of a similar size
- PRIMPrimoris Services Corporation
- TNGXTango Therapeutics, Inc.
- SMGScotts Miracle-Gro Co
- TNETTRINET GROUP, INC.
- XENEXENON PHARMACEUTICALS INC.
Not investment advice. This page shows what Mueller Water Products, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.